DCGI allows Phase II-III clinical trial of Covaxin on 2-18 year olds
New Delhi: The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of ...
Read moreDetails
New Delhi: The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of ...
Read moreDetails
With the retail inflation in India climbing to 4.38 per cent, tell tale signs of the global economic crisis have...
Read moreDetails
US President Donald Trump has pressed the war button again. Tehran too has responded with the same tactic it used...
Read moreDetails
Former Bangladesh Prime Minister Sheikh Hasina’s announcement during an interview with news agency Reuters that she intends to return to...
Read moreDetails
By Aakar Patel One common trait in lawless nations is a high level of anxiety regarding arbitrariness. Medieval texts tell...
Read moreDetails